Company Analysis

Amneal Pharmaceuticals, Inc. (AMRX)

Nasdaq: AMRX · Pharmaceutical Preparations · filing with the SEC since 2017
Grade5.3
◀ Past 4.9● Present 6.3▶ Future 4.3

Who runs Amneal Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Patel Chintu
Co-CEO. First filing May 2018, latest Aug 12, 2026, 3 filings in all.
Officers reporting now
6
of 14 people with a filing in the last fifteen months
Directors reporting now
8
30 people on the record since 2018
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Boyer Andrew SExecutive Vice PresidentMay 2018Sep 2, 2026none
Shah NikitaExecutive Vice PresidentMay 2018Aug 13, 20262 · $4.1M
Daly Jason B.EVP, Chief Legal OfficerJan 2022Aug 13, 20262 · $3.8M
Patel ChintuCo-CEOMay 2018Aug 12, 2026none
Patel Chirag K.President & Co-CEOMay 2018Aug 12, 2026none
Konidaris TasosExecutive Vice President & CFOMar 2020Mar 5, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Buchi J KevindirectorMay 2018Sep 21, 2026none
Kiely JohndirectorDec 2019Aug 14, 20261 · $900,000
Patel GautamdirectorMay 2018Aug 12, 2026none
Autor Deborah M.directorAug 2022May 12, 20261 · $500,000
George Jeffrey P.directorDec 2019May 8, 2026none
Meister Paul MdirectorAug 2019May 8, 2026none
Nark Ted CdirectorMay 2018May 8, 20261 · $600,000
Yanai ShlomodirectorDec 2019May 8, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Patel Tushar Bhikhubhai10% ownerJul 2018Aug 12, 2026none
Earlier names on the record25, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton AMRX · research, not advice